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Abstract
Background: The NPC1 gene encodes a protein involved in intracellular lipid trafficking; its second endosomal
loop (loop 2) is a receptor for filoviruses. A polymorphism (His215Arg) in NPC1 was associated with obesity in
Europeans. Adaptations to diet and pathogens represented powerful selective forces; thus, we analyzed the
evolutionary history of the gene and exploited this information for the identification of variants/residues of
functional importance in human disease.
Methods: We performed phylogenetic analysis, population genetic tests, and genotype-phenotype analysis in a
population from Saudi Arabia.
Results: Maximum-likelihood ratio tests indicated the action of positive selection on loop 2 and identified three
residues as selection targets; these were confirmed by an independent random effects likelihood (REL) analysis. No
selection signature was detected in present-day human populations, but analysis of nonsynonymous
polymorphisms showed that a variant (Ile642Met, rs1788799) in the sterol sensing domain affects a highly
conserved position. This variant and the previously described His215Arg polymorphism were tested for association
with obesity and type 2 diabetes (T2D) in a cohort from Saudi Arabia. Whereas no association with obesity was
detected, 642Met allele was found to predispose to T2D. A significant interaction was noted with sex (P = 0.041),
and stratification on the basis of gender indicated that the association is driven by men (P = 0.0021, OR = 1.5).
Notably, two NPC1 haplotypes were also associated with T2D in men (rs1805081-rs1788799, His-Met: P = 0.0012,
OR = 1.54; His-Ile: P = 0.0004, OR = 0.63).
Conclusions: Our data indicate a sex-specific effect of NPC1 variants on T2D risk and describe putative binding
sites for filoviruses entry.
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Background
The NPC1 gene encodes a large multi-domain protein
involved in the intracellular trafficking of sterols. Muta-
tions in the gene are responsible for a rare and fatal
lipid storage disorder, Niemann-Pick disease type C.
The product of NPC1 resides in the limiting membrane
of late endosomes and lysosomes where it facilitates
lipid transport to various cellular compartments
(reviewed in [1]). The protein displays 13 transmem-
brane domains, and three large loops are present in the
lumen of the endosome (Figure 1) [2]. Interaction with
lipid substrates is mediated by the most N-terminal
luminal loop (loop 1) and by a sterol-sensing domain
(SSD) which comprises five central transmembrane
regions [2] (Figure 1). Recent works showed that the
subcellular localization of NPC1 has been exploited by
viruses of the Filoviridae family for host invasion [3-5].
Thus, viruses such as Ebola and Marburg require NPC1
protein expression for productive infection and the
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second luminal domain of NPC1 binds directly and spe-
cifically to the GP1 viral glycoprotein [3]. Consistently,
primary fibroblasts from human Niemann-Pick type C1
disease patients are resistant to infection by filoviruses
[4].
Mice lacking Npc1 function display a phenotype recapi-
tulating Niemann-Pick disease type C [6], whereas hap-
loinsufficiency for the gene results in weight gain and
insulin resistance [7,8]. In fact, Npc1+/- mice display
increased adiposity and adipocyte hypertrophy; these ani-
mals also show dyslipidemia and higher plasma glucose
levels compared to their wild-type litter mates. In line
with this evidence, a nonsynonymous polymorphism
(rs1805081, His215Arg) in the human NPC1 gene has
recently been associated with severe and early onset obe-
sity in European populations [9]. A subsequent study
confirmed the predisposing role of rs1805081 to obesity
and increased body mass index (BMI) in Europeans, but
found no association between the variant and type 2 dia-
betes (T2D) or fasting plasma lipid levels [10]. Conver-
sely, the effect on obesity risk and higher BMI of the
NPC1 SNP in Asian populations is still controversial
[11,12]. The molecular mechanisms underlying the asso-
ciation between genetic variation in NPC1 and metabolic
phenotypes remain to be clarified. However, analysis of
Npc1 mutant mice revealed that these animals are char-
acterized by increased liver accumulation of triacylgly-
cerol [7], higher hepatic expression of caveolin-1 [13], a
protein involved in liver lipid metabolism [14], and of
sterol regulatory element-binding proteins (SREBPs) [15].
These observations suggest that mutations or poly-
morphisms in NPC1 result in alteration of hepatic lipid
homeostasis eventually leading to weight gain and insulin
resistance.
Adaptations to diet and to pathogen exposure are
thought to have represented a powerful driving force
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Figure 1 Schematic representation of the NPC1 protein (not to scale). Cylinders represent the transmembrane regions; the SSD domain is
depicted in grey. Luminal loop 2 is represented in blue and red to account for the recombination breakpoint. The position of the three
positively selected sites in loop 2 is shown (yellow circles) with the alignment of a few representative mammalian species. The position of
nonsynonymous polymorphisms with a minor allele frequency higher than 1% is represented by the green circles. SSD, sterol sensing domain
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throughout the evolutionary history of mammals [16].
Thus, we performed a phylogenetic analysis of NPC1
genes in mammals and a population genetics study of
diversity in human populations. We identified three resi-
dues that have been targets of positive selection, possibly
mediated by filovirus-exerted selective pressure. No
selection signature was detected in present-day human
populations, but analysis of nonsynonymous polymorph-
isms identified a variant (Ile642Met) in the SSD domain
that affects a highly conserved position. This variant and
NPC1 haplotypes were found to modulate the risk of
T2D (but not BMI or obesity) in a population from
Saudi Arabia.
Methods
Evolutionary analysis
Most mammalian NPC1 sequences were retrieved from
the Ensembl website [17]. The sequence of baboon was
obtained though blast search in the National Center for
Biotechnology Information (NCBI) Trace Archive against
Papio hamadryas whole genome sequence. NPC1 coding
sequences for Cricetulus griseus and Mustela putorius
(C-terminal portion only) were retrieved from the NCBI
nucleotide database (NM_001246687.1 and JP014452,
respectively).
DNA alignment was performed using the The RevTrans
2.0 utility [18], which uses the peptide sequence alignment
[see Additional file 1, Figure S1] as a scaffold for con-
structing the corresponding DNA multiple alignment.
This latter was checked and edited by hand to remove
alignment uncertainties. The alignment was used for
Genetic Algorithm Recombination Detection (GARD) [19]
analysis through the DataMonkey [20]. Similarly, the evo-
lutionary selection distance (ESD), random effects likeli-
hood (REL) and branch-site REL analyses were performed
using DataMonkey [20]. For phylogenetic analysis by max-
imum likelihood (PAML) analyses we used multiple align-
ments of NPC1 sub-regions and trees generated by
maximum-likelihood using the program DnaML (PHYLIP
Package). To detect selection, Nssite models that allow
(M8) or disallow (M7 and M8a) a class of codons to evolve
with dN/dS >1 were fitted to the data using both the F61
(Table 1) and the F3X4 [see Additional file 1, Table S1]
codon frequency models. Sites under selection for the M8
model were identified using Bayes empirical Bayes (BEB)
analysis using a significance cutoff of 0.90 [21,22].
Population genetic analyses
Data from the Pilot 1 phase of the 1000 Genomes Project
were retrieved online [23]. Low-coverage SNP genotypes
were organized in a MySQL database. A set of programs
was developed to retrieve genotypes from the database
and to analyze them according to selected regions/popula-
tions. These programs were developed in C++ using the
GeCo++ [24] and the libsequence [25] libraries. Genotype
information was obtained for NPC1 and for 2,000 ran-
domly selected RefSeq genes.
Sliding window analysis was performed on overlapping
5 kb windows moving with a step of 500 bp. For each
window we calculated θW, π, and FST and these values
were used to obtain the empirical distributions and to
calculate percentiles. Values for the integrated haploty-
pe_score (iHS) for HapMap Phase II SNPs were derived
from a previous work [26].
Patients and controls
All subjects recruited in the study are part of the Biomar-
ker Screening in Riyadh Project (RIYADH COHORT), a
capital-wide epidemiologic study that has so far enrolled
more than 17,000 Saudis from different Primary Health
Care Centers. Demographic and medical information is
recorded for all individuals participating in the program.
DNA samples have been collected from more than 1,600
of these individuals. These individuals were selected to
represent case-control cohorts for T2D. Subjects with
medical complications (coronary artery disease, nephropa-
thy, and end stage renal disease or liver disease) were
excluded and a similar percentage of men and women
were enrolled among T2D patients and controls. After dis-
carding samples with poor DNA quality, 1,468 subjects
were included in the study (644 T2D, 52% women; 824
controls, 54% women). Diagnosis of T2D was based on the
World Health Organization proposed cut-off (fasting
plasma glucose > or = 7.0 mmol/L or 126 mg/dl) as pre-
viously described [27].Written consent was obtained from
all participants, and ethical approval was granted by the
Ethics Committee of the College of Science Research
Center, King Saud University, Riyadh, Kingdom of Saudi
Arabia (KSA).
Anthropometry and DNA extraction
After an overnight fast, subjects underwent anthropome-
try and blood withdrawal. Anthropometry included mea-
surement of height (to the nearest 0.5 cm) and weight
(to the nearest 0.1 kg); BMI was calculated as kg/m2.
According to the World Health Organization (WHO)
criteria, individuals were classified as obese if their BMI
was > 30 kg/m2. Whole blood was collected in ethylene-
diaminetetraacetic acid (EDTA)-containing tubes; geno-
mic DNA was isolated using the blood genomic prep
minispin kit (GE Healthcare, Milano, Italy). Genotyping
and statistical analysisThe two NPC1 SNPs were geno-
typed by allelic discrimination real-time PCR, using pre-
designed TaqMan probe assays (Applied Biosystems,
Foster City, CA, USA). Reactions were performed using
TaqMan Genotyping Master Mix in an ABI 9700 analy-
zer (Applied Biosystems). Genotyping rate was >0.97 for
both variants. In the text and tables, the allelic status of
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the two variants is shown with reference to the tran-
script orientation with the ancestral allele reported first.
Genetic association was investigated by multiple linear
or logistic regression (as appropriate) using genotypes/
haplotypes as the independent predictor variables with
sex and age as covariates; BMI was added as a covariate
when addressing the association between T2D and
NPC1 variants; T2D was accounted for when addressing
the effect of SNPs/haplotypes on obesity and BMI.
Before carrying out parametric statistical procedures,
total cholesterol and triglyceride levels were logarithmi-
cally transformed to ensure a more normal distribution.
Analyses were performed using PLINK [28].
Results
Evolutionary analysis of NPC1 mammalian genes
To analyze the evolutionary history of NPC1 in mammals
we retrieved coding sequence information for 41 species
from public databases (see methods). Alignment of these
sequences revealed that NPC1 evolved under purifying
selection, as the average non-synonymous substitution
rate (dN) was generally much lower than the rate for
synonymous substitutions (dS) (average dN/dS = 0.12).
Nonetheless, natural selection might act on a few sites
within a gene that is otherwise strongly constrained.
Before testing this possibility, we screened the NPC1
alignment for evidence of recombination using a recently
developed algorithm (GARD) [19]; this analysis uncov-
ered the presence of one single recombination breakpoint
at nucleotide position 1619 (ΔAICc = 53.7), falling within
luminal loop 2 (Figure 1). After taking this information
into account, we analyzed the evolutionary fingerprint of
NPC1 by applying the ESD method [29], which uses the
site-by-site probability distribution of synonymous and
nonsynonymous substitution rates to partition sites into
selective classes. ESD estimated 10 substitution rate
classes (Figure 2), one of which showing dN/dS (ω) >1,
indicative of positive selection. Specifically, the estimated
average ω for this class was 1.98 with an estimated per-
centage of sites of 2% (95% IC: 0.1 to 0.3). We next
applied maximum-likelihood analyses implemented in
the PAML package [30,31] to single NPC1 domains. Spe-
cifically, we separately analyzed luminal loops 1 and 3, as
well as the SSD domain; luminal loop 2 was divided into
two halves to account for the recombination breakpoint.
Results indicated that a model allowing sites to evolve
with ω >1 (M8) had significantly better fit to the data
than models assuming no positive selection (M7 and
M8a) for the N-terminal portion of loop 2 (Table 1, and
Additional file 1, Table S1). Some evidence of positive
selection was also evident for loop 1. No selection signa-
ture was detected for the remaining NPC1 regions. Three
sites in the N-terminal portion of loop 2 were found to
have a high posterior probability of being under positive
selection according to BEB analysis (P >0.90) (Table 1
Figure 1) [21,22]. These three sites were confirmed by an
independent REL analysis that allows variation of dS
among sites [32] (Table 1). BEB analysis also identified
one site in luminal loop 1, which was not confirmed by
REL analysis. Finally, we verified whether any lineage
Table 1 Likelihood ratio test statistics for models of variable selective pressure among sites (F61 model of codon
frequency).
Region/selection model(number of codons) d.f. -2ΔLnL P value % of sites(average dN/dS) Selected sites
Loop1 (269)
M7 versus M8 2 10.04 0.0066 1.3% (1.37) 182 (0.99, n.s.)
M8a versus M8 1 4.87 0.027 - -
Loop 2 N-term (251)
M7 versus M8 2 25.86 <0.0001 1.3% (1.78) 416 (0.99, 0.99),417 (0.98, 1), 421 (0.91, 0.99)
M8a versus M8 1 10.98 0.0009 -
Loop 2 C-term (81)
M7 versus M8 2 <0.01 >0.99 - -
M8a versus M8 1 1.96 0.16 -
SSD (164)
M7 versus M8 2 5.70 0.058 - -
M8a versus M8 1 0.02 >0.88 - -
Loop 3 (248)
M7 versus M8 2 0.004 >0.99 - -
M8a versus M8 1 1.52 0.21 - -
M7 is a null model that assumes that 0<ω<1 is beta distributed among sites; M8a assumes 0<ω≤1; these two models are compared to M8, which includes an
extra category of sites with ω>1 (positive selection). d.f., degree of freedom; 2ΔLnL, twice the difference of the natural logs of the maximum likelihood of the
models being compared; P value, P value of rejecting the neutral models (M7 or M8a) in favor of the positive selection model (M8); % of sites (average dN/dS),
estimated percentage of sites evolving under positive selection by M8 (dN/dS for these codons); selected sites, the position refers to the entire NPC1 human
sequence, P values obtained from BEB and REL analyses are shown. BEB, Bayes empirical Bayes; REL, random effects likelihood; SSD, sterol sensing domain.
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shows evidence of episodic positive selection by applying
a branch-site REL analysis [33]. Results indicated that a
proportion of sites has evolved under episodic diversify-
ing selection in the gorilla and baboon lineages, although
the proportion of sites evolving with ω >1 was very low
(about 1%) in both lineages. Thus, the branch-site REL
test should be interpreted with caution, as sequencing
errors in the reference sequences of these two primates
might be partially responsible for these results [see Addi-
tional file 1, Figure S2].
Population genetics in humans
The human NPC1 gene spans about 55 kb on chromo-
some 18. To gain insight into its evolutionary history in
human populations, we exploited sequencing data from
the 1000 Genomes Pilot Project [34], which generated
low-coverage whole genome sequencing data of 179
individuals with different ancestry (Yoruba from Nigeria,
Europeans and Asians). Nucleotide diversity for the
entire NPC1 gene region was calculated using θW, an
estimate of the expected per site heterozygosity [35] and
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Figure 2 Evolutionary fingerprint of NPC1. The estimate of the distribution of synonymous and nonsynonymous substitution rates is plotted
on a log-log scale. The ellipses reflect a Gaussian-approximated variance in each individual rate estimate, and colored pixels show the density of
the posterior sample of the distribution for a given rate. The diagonal line represents the neutral evolution expectation (ω = 1), points above the
line correspond to positive selection (ω >1), and points below the line to purifying selection (ω <1)
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π, the average number of pair-wise sequence nucleotide
differences between haplotypes [36]. As a comparison,
the same indexes were obtained for 2,000 randomly
selected human genes. Both θW and π for NPC1 ranged
from the 29th to the 40th percentiles in the distribution
of values calculated for the 2,000 reference genes in the
three populations (not shown). In order to address the
possibility of local selection affecting NPC1 sub-regions,
we performed a sliding window analysis of θW, π, and
Yoruba/European/Asian population genetic differentia-
tion (FST) [37] along the gene. Again, we applied the
same procedure to 2,000 randomly selected human
genes, allowing calculation of the 2.5th and 97.5th per-
centiles to be used as reference cutoffs. No region in
NPC1 displayed nucleotide diversity outside the calcu-
lated cutoffs [see Additional file 1, Figure S3]. As for
FST, a peak was evident in the middle of the gene, but it
did not exceed the 97.5th percentile [see Additional file
1, Figure S4]. Analysis of iHS [26] for variants within
the peak revealed no absolute value higher than 2 (data
not shown). Overall, these analyses suggest that NPC1 is
neutrally evolving in humans or that selection signatures
are too weak to be detected using these approaches.
Association of NPC1 SNPs with obesity and T2D
To shed light on the distribution of polymorphisms seg-
regating in NPC1 we again exploited the 1000 Genomes
Project data [34] by selecting nonsynonymous variants
that have been detected in the gene with a minor allele
frequency higher than 1%. Six variants were identified;
only two of them were located in domains possibly affect-
ing sterol homeostasis: rs1805081 (His215Arg), located in
loop 1 and previously associated with obesity in Eur-
opeans [9], and rs1788799 (Ile642Met), located in the
SSD (Figure 1). Analysis of the mammalian NPC1 align-
ment indicated that codon 215 is relatively variable,
whereas position 642 is conserved (Ile) in all species [see
Additional file 1, Figure S1]. We analyzed the role of these
two SNPs in predisposing to obesity and weight gain by
recruiting a population consisting of 1,468 subjects (820
obese individuals and 648 non-obese controls) from Saudi
Arabia (Table 2). The two polymorphisms displayed lim-
ited linkage disequilibrium (LD) in our study population
(D’ = 0.93, r2 = 0.080) and both complied with Hardy-
Weinberg equilibrium. Minor allele frequencies for
rs1788799 (G, 642Met) and rs1805081 (G, 215Arg) in this
cohort amounted to 0.41 and 0.12, respectively. Association
of these SNPs with obesity was assessed by fitting a logistic
regression model using age, sex, and absence/presence of
T2D as covariates. Results indicated that neither SNP
associates with obesity (Table 3). Similarly, no association
between NPC1 variants and BMI was detected (Table 3).
We next evaluated the role of rs1805081 and rs1788799
in predisposing to T2D; to this aim all subjects were ana-
lyzed by fitting a logistic regression using age, sex, and
BMI as covariates. No effect of rs1805081 on T2D sus-
ceptibility was observed; conversely, a significant associa-
tion between rs1788799 and T2D was detected (for the
minor allele 642Met, P = 0.0137, odds ratio (OR) = 1.24)
(Table 3). A significant interaction was also noted
between allelic status at this variant and sex (Pinteraction =
0.041); stratification of the population on the basis of
gender indicated that the association between rs1788799
and T2D is driven by male subjects (Table 3). Thus, we
next analyzed the effect of NPC1 haplotypes on suscept-
ibility to diabetes. After correcting for age, sex and BMI,
two haplotypes were found to be associated with T2D
with an opposite effect. Specifically, AC and AG
(rs1805081-rs1788799, 215His-642Ile and 215His-
642Met) haplotypes were observed to protect and predis-
pose to the disease, respectively (Table 4). Again, the
association could only be detected in men and occurred
in both obese and non-obese individuals (Table 4).
Finally, we evaluated the role of NPC1 haplotypes in
modulating fasting plasma lipid levels. Circulating levels of
total-, LDL- and HDL-cholesterol, as well as triglycerides
were available for 1,443 individuals of the above described
cohort. No effect of NPC1 haplotypes on total- and LDL-
cholesterol was detected (Table 5). Conversely, different
NPC1 haplotypes were associated, although weakly, with
HDL-cholesterol and triglyceride levels both in men and
women (Table 5).
Discussion
During mammalian evolution genes involved in diet and
immune response have been preferential targets of positive
Table 2 Characteristics of the Saudi cohort.
Obese Non-obese
T2D No T2D T2D No T2D
Sample size 441 379 203 445
Females (%) 261 (59) 233 (61) 73 (36) 216 (48.5)
Males (%) 180 (41) 145 (39) 130 (64) 229 (51.5)
Age ± s.d. (years) 53.07 ± 10.61 42.79 ± 10.15 55.54 ± 16.19 38.56 ± 13.90
BMI ± s.d., kg/m2 35.62 ± 6.83 34.67 ± 3.92 24.25 ± 3.31 22.74 ± 3.3
T2D, type 2 diabetes.
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selection [16], highlighting the role of nutrient availability/
preferences and pathogens as powerful selective forces.
The protein product of NPC1 plays a central role in lipid
metabolism, as it acts as a cholesterol transporter and its
transcription is regulated by the SREBP pathway [1]. Con-
versely, the gene does not participate in immune response,
but is exploited by members of the filovirus family as an
intracellular receptor that mediates the late steps of viral
invasion [3-5]. Evidence has indicated that genes directly
involved in antiviral response or acting as viral receptors
(for example, HAVCR1, CD4) display domains evolving
under positive selection as the result of a genetic conflict
with extant or extinct viral species [38-46]. Positive selec-
tion at these host genes may result from adaptation either
to increase viral recognition and restriction efficiency or to
avoid binding of specific viral components. Our evolution-
ary analysis in mammals indicated a predominant role of
purifying selection in driving the evolution of NPC1 but
also identified few positions that have been targeted by
positive selection. Specifically, maximum-likelihood ratio
tests indicated that three residues in the N-terminal por-
tion of luminal loop 2 evolved under positive selection;
these codons are located in close proximity to each other,
and selection was confirmed by an independent REL ana-
lysis. PAML also identified one positively selected site in
luminal loop 1, but this was not supported by REL, sug-
gesting that it may represent a false positive, as the M8
model has been shown to be more prone than REL to
false positive results when a relatively high number of
sequences (species) is used for analysis [47]. These results
suggest that the selective pressure responsible for positive
selection in NPC1 stems from pathogens rather than from
dietary changes. Indeed, a recent study has indicated that
luminal loop 2 is necessary and sufficient to bind filovirus
GP1 protein directly and to mediate productive infection
[3]; the authors were able to map the GP1 residues
involved in engaging loop 2 and determined that they are
conserved among filoviruses [3]. This observation,
Table 3 Association analysis of NPC1 polymorphisms with obesity, BMI, and T2D.
Trait Minor allele Whole sample Males Females
P valuea OR (95% CI)b P valuea OR (95% CI)b P valuea OR (95% CI)b
Obesity
rs1788799 (C/G) G (Met) >0.5 1.05 (0.87 to 1.18) >0.5 1.02 (0.81 to 1.27) >0.5 1.02 (0.83 to 1.27)
rs1805081 (A/G) G (Arg) >0.5 0.83 (0.78 to 1.25) >0.5 1.06 (0.76 to 1.47) >0.5 0.93 (0.67 to 1.30
BMI P valuea BETAc P valuea BETAc P valuea BETAc
rs1788799 (C/G) G (Met) 0.462 0.328 >0.5 0.490 >0.5 0.231
rs1805081 (A/G) G (Arg) >0.5 -0.411 >0.5 -0.343 >0.5 -0.450
T2D P valuea OR (95% CI)b P valuea OR (95% CI)b P valuea OR (95% CI)b
rs1788799 (C/G) G (Met) 0.027 1.24 (1.05 to 1.48) 0.004 1.50 (1.15 to 1.95) >0.5 1.07 (0.85 to 1.36)
rs1805081 (A/G) G (Arg) >0.5 1.06 (0.82 to 1.39) >0.5 1.11 (0.76 to .60) >0.5 1.04 (0.71 to 1.52)
aP values were calculated using logistic or linear regression (as appropriate) with an additive model; Bonferroni-corrected P values are reported; nominally
significant P values are in bold; bodds ratio and 95% confidence intervals refer to the minor allele. cregression coefficient. BMI, body mass index; OR, odds ratio;
T2D, type 2 diabetes.
Table 4 Association analysis of NPC1 haplotypes with T2D.
Trait Haplotype
(rs1805081 -rs1788799, residues)
Whole sample Males Females
Freq.a P value (OR) Freq.a P value (OR) Freq.a P value (OR)
T2D (all)
GC (Arg-Ile) 0.12 0.451 (1.11) 0.12 0.495 (1.14) 0.12 0.653 (1.09)
AG (His-Met) 0.41 0.009 (1.26) 0.40 0.0012 (1.54) 0.41 0.545 (1.08)
AC (His-Ile) 0.47 0.003 (0.77) 0.48 0.0004 (0.63) 0.47 0.425 (0.91)
T2D (obese)
GC (Arg-Ile) 0.12 0.577 (1.10) 0.12 0.498 (1.20) 0.12 0.780 (1.07)
AG (His-Met) 0.42 0.230 (1.14) 0.42 0.013 (1.44) 0.41 0.745 (0.95)
AC (His-Ile) 0.46 0.142 (0.85) 0.46 0.004 (0.60) 0.47 0.813 (1.03)
T2D (non-obese)
GC (Arg-Ile) 0.11 0.77 (1.07) 0.11 0.957 (1.02) 0.12 0.666 (1.19)
AG (His-Met) 0.40 0.0125 (1.46) 0.40 0.033 (1.52) 0.41 0.158 (1.40)
AC (His-Ile) 0.49 0.009 (0.67) 0.49 0.042 (0.69) 0.47 0.088 (0.65)
ahaplotype frequency. Significant P values are in bold. Freq., frequency; T2D, type 2 diabetes.
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together with evidence showing that NPC1 is required for
infection of both human and rodent cells by distantly
related viral species, strongly suggests that the cholesterol
transporter is a necessary factor for most members of the
Filoviridae family [3-5]. These pathogens display a wide
host range in mammals [48] and are thought to have
affected vertebrates for millions of years, as testified by the
detection of filovirus-derived elements in the genome of
both eutherians and marsupials [49]. Thus, we suggest
that the positively selected sites we identified in luminal
loop 2 evolved in response to a host-filovirus arms race
and might represent relevant residues in mediating GP1
binding.
Population genetic analysis of NPC1 in humans revealed
no evident signature of natural selection in loop 2 or any
other gene region, although we cannot exclude that weak
or geographically-restricted selective events have acted on
the gene. With respect to filovirus infection, this might
not be surprising as the known human pathogens Ebola
and Marburg viruses are highly virulent agents that rapidly
kill infected individuals, a feature that possibly limits their
spreading in human populations [50] and makes them
unlikely candidates to play a role as selective agents.
Genetic diversity in human NPC1 has nevertheless been
recently associated with metabolic dysfunction, this asso-
ciation being based on the central role of the gene in lipid
trafficking. Specifically, the His215Arg (rs1805081) variant
in luminal loop 1, which is involved in cholesterol binding,
was shown to associate with obesity in populations of
European descent [9,10]. It has been proposed that alleles
responsible for obesity and T2D might have evolved as
‘thrifty’ variants in ancient populations [51,52]. In line with
this hypothesis, selection signatures have been detected for
a few polymorphisms associated with these conditions
[53,54], although this does not seem to be the case for
NPC1. Nonetheless, inspection of nonsynonymous SNPs
located in the gene revealed that, in addition to the above
mentioned variant in loop 1, a polymorphism (Ile642Met,
rs1788799) in the SSD domain segregates at relatively high
frequency in human populations and affects an isoleucine
residue which is conserved in all the mammals we
analyzed.
We thus reasoned that this SNP might affect NPC1
function and modulate metabolic phenotypes. We tested
this hypothesis in a large cohort of subjects from Saudi
Arabia, a region where the prevalence of obesity and T2D
is very high [55-57]. The previously described association
between rs1805081 and obesity [9,10] was not replicated
in the Saudi sample, although the relatively lower minor
allele frequency (MAF) of the variant in this population
(12%) compared to Europeans (ranging from 25% to 40%)
might have limited our detection power. No effect on BMI
or obesity was detected in the Saudi cohort for the Ile642-
Met variant either. Similarly, the role of the His215Arg
variant in predisposing to obesity was not observed in a
cohort of Chinese children [12], although a possible inter-
action between this (and other) variant and sedentary
behavior has been described in a population of the same
ethnicity [11]. Recently, a meta-analysis of rs1805081 on
obesity risk in Europeans also revealed a weak effect of the
polymorphism on body fat percentage, but not on BMI or
on the odds of being obese [58]. One possibility to explain
Table 5 Association analysis of NPC1 haplotypes with lipid levels.
Trait Haplotype
(rs1805081-rs1788799, residues)
Whole sample Males Females
BETAa P value BETAa P value BETAa P value
HDL-cholesterol
GC (Arg-Ile) -0.047 0.026 -0.070 0.017 -0.020 0.698
AG (His-Met) -0.013 0.32 0.004 0.803 -0.0278 0.048
AC (His-Ile) 0.032 0.015 0.025 0.190 0.040 0.023
LDL-cholesterol
GC (Arg-Ile) -0.068 0.650 -0.140 0.477 -0.034 0.877
AG (His-Met) 0.149 0.124 -0.125 0.330 0.200 0.157
AC (His-Ile) -0.105 0.265 -0.701 0.583 -0.144 0.289
Total cholesterol
GC (Arg-Ile) -0.011 0.408 0.003 0.872 -0.028 0.166
AG (His-Met) 0.010 0.224 0.002 0.873 0.022 0.097
AC (His-Ile) -0.005 0.538 -0.003 0.794 -0.008 0.505
Triglycerides
GC (Arg-Ile) 0.045 0.101 0.104 0.003 -0.0313 0.466
AG (His-Met) 0.024 0.173 -0.014 0.563 0.071 0.009
AC (His-Ile) -0.041 0.018 -0.031 0.181 -0.052 0.046
aregression coefficient. Significant P values are in bold.
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these contrasting results is that variants in NPC1 interact
with environmental cues, as suggested by the Chinese
study [11] and possibly with additional genetic factors.
This seems to be the case for Npc1+/- mice: these animals
develop increased adiposity and metabolic disturbances
but the phenotype depends on both fat intake and genetic
background [7,59]. These animals also present with
increased fasting plasma glucose levels, glucose intoler-
ance, and insulin resistance, indicating a T2D phenotype
[7,59]. Somehow in contrast with these results, a recent
study indicated that heterozygosity for a hypomorphic
Npc1 mutation on the C57BL/6J ‘metabolic syndrome’
genetic background protects old male mice, but not
females, from weight gain [60]. Overall, these observations
suggest that Npc1 genetic variation interacts with diet, sex
and with one or more gene(s) in modulating metabolic
phenotypes.
A possible association between the two NPC1 variants
and T2D was analyzed in the Saudi cohort. Overweight
and obesity are strong risk factors for the development of
T2D; genetic susceptibility is nevertheless believed to play
a stronger role in non-obesity related T2D [61]. Thus, we
verified the effect of rs1805081 and rs1788799 on diabetes
susceptibility by taking BMI into account; a significant
association was detected between rs1788799 and T2D,
with a predisposing role for the derived 642Met allele.
Several metabolic traits are sexually dimorphic in
humans and/or show sex-specific heritability linked to the
autosomes [62]. Thus, it was suggested that variants with a
sex-specific effect might be difficult to detect without
separating the sexes or modeling for gender-based differ-
ences [62]. Testing for interaction with sex in our cohort
indicated the presence of a significant effect; stratification
of the population on the basis of gender revealed that the
association is driven by male subjects. This was even more
evident when haplotype analysis using the two coding var-
iants was performed. Notably, two major haplotypes
showed an opposite effect on T2D susceptibility in men
only, and the effect was evident in both obese and non-
obese individuals. An interaction between gender and
genetic factors has been described for some other genes
involved in T2D [63-66]; the reasons underlying these sex-
specific events remain to be elucidated and might include
a role for sex hormones, epistatic effects with X-linked
variants, or differences in dietary habits and lifestyle
between the sexes that, in turn, interact with the genetic
status.
Further analyses on plasma lipid levels showed the pre-
sence of different associations with NPC1 haplotypes in
men and women. Nonetheless, these effects were generally
weak and should be interpreted with caution. The stronger
effect was detected for triglyceride levels. Thus, in men a
minor haplotype unrelated to T2D susceptibility was
found to associate with higher levels, whereas in women
the two major haplotypes that predispose or protect men
from diabetes were found to be associated with higher and
lower triglyceride levels, respectively.
Conclusions
Data reported here indicate that NPC1 has evolved adap-
tively in mammals and that the underlying selective pres-
sure might be virus-driven. No selection signature was
detected in present-day human populations, but analysis
of nonsynonymous polymorphisms showed that a variant
(Ile642Met) in the SSD domain affects a highly conserved
position. This variant and haplotypes comprising Ile642-
Met and the previously described His215Arg polymorph-
ism were found to modulate the risk of T2D in a
population from Saudi Arabia with a sex-specific effect.
Analysis of additional cohorts will be instrumental for
clarifying the role of the two NPC1 variants on plasma
lipid levels and T2D susceptibility. Our results indicate
that haplotype analysis (as opposed to single variant asso-
ciation) and modeling for sex-specific effects are strongly
recommended when NPC1 genetic variability is analyzed.
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